drugset / Trial / NCT00546351
Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.
NaSingle-groupOpen-labelTreatment
Summary
SP746 (NCT00546351) is a multi-center, open-label, follow-on trial. The purpose of this trial is to assess safety and tolerability of long-term exposure of lacosamide (previously referred to as SPM 927) in subjects with painful distal diabetic neuropathy.
Timeline
- Start
- 2004-05
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 50 mg | — |
| Subject | Lacosamide | Other / unclassified | 100 mg | — |
| Subject | Lacosamide | Other / unclassified | 600 mg | — |